Prognosis and Natural History of Drug-Related Bradycardia

Jang Hoon Lee(Chungnam National University), Wee‐Hyun Park(Kyungpook National University Hospital), Myung Hwan Bae(Kyungpook National University Hospital), Dong Heon Yang(Kyungpook National University Hospital), Yongwhi Park(Gyeongsang National University Hospital), Yongkeun Cho(Kyungpook National University Hospital), Yoon-Nyun Kim(Keimyung University Dongsan Medical Center), Jung Ho Heo(Kosin University), Yong Seop Kwon(Kyungpook National University Hospital), Shung Chull Chae(Kyungpook National University Hospital), Hun Sik Park(Kyungpook National University Hospital), Jae‐Eun Jun(Kyungpook National University Hospital), Ju Hwan Lee(Gumi University), Hyeon Min Ryu(Kyungpook National University Hospital), Young Soo Lee(Government of the Republic of Korea)
Korean Circulation Journal
January 1, 2009
10.4070/kcj.2009.39.9.367
Cited by 39

Related Papers

Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
|The Lancet|2018|372
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
|The Lancet|2022|304